| # | Title | Journal | Year | Citations |
|---|
| 1 | Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes | Translational Neurodegeneration | 2020 | 883 |
| 2 | Neuroinflammation in Parkinson’s disease and its potential as therapeutic target | Translational Neurodegeneration | 2015 | 608 |
| 3 | The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration | Translational Neurodegeneration | 2015 | 439 |
| 4 | Protein misfolding in neurodegenerative diseases: implications and strategies | Translational Neurodegeneration | 2017 | 424 |
| 5 | Alzheimer’s disease hypothesis and related therapies | Translational Neurodegeneration | 2018 | 385 |
| 6 | Current understanding of the molecular mechanisms in Parkinson's disease: Targets for potential treatments | Translational Neurodegeneration | 2017 | 353 |
| 7 | Current understanding of metal ions in the pathogenesis of Alzheimer’s disease | Translational Neurodegeneration | 2020 | 219 |
| 8 | The dual roles of cytokines in Alzheimer’s disease: update on interleukins, TNF-α, TGF-β and IFN-γ | Translational Neurodegeneration | 2016 | 211 |
| 9 | The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease | Translational Neurodegeneration | 2019 | 200 |
| 10 | Blocking meningeal lymphatic drainage aggravates Parkinson’s disease-like pathology in mice overexpressing mutated α-synuclein | Translational Neurodegeneration | 2019 | 187 |
| 11 | Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts | Translational Neurodegeneration | 2017 | 177 |
| 12 | Current advances in using neurotrophic factors to treat neurodegenerative disorders | Translational Neurodegeneration | 2012 | 170 |
| 13 | The changing phenotype of microglia from homeostasis to disease | Translational Neurodegeneration | 2012 | 168 |
| 14 | The role of statins in both cognitive impairment and protection against dementia: a tale of two mechanisms | Translational Neurodegeneration | 2018 | 147 |
| 15 | Meta-analyses on prevalence of selected Parkinson’s nonmotor symptoms before and after diagnosis | Translational Neurodegeneration | 2015 | 145 |
| 16 | The effects of exercise on cognition in Parkinson’s disease: a systematic review | Translational Neurodegeneration | 2014 | 139 |
| 17 | Music therapy is a potential intervention for cognition of Alzheimer’s Disease: a mini-review | Translational Neurodegeneration | 2017 | 139 |
| 18 | Factors that influence adult neurogenesis as potential therapy | Translational Neurodegeneration | 2018 | 134 |
| 19 | Mitochondrial dysfunction in Parkinson’s disease | Translational Neurodegeneration | 2016 | 129 |
| 20 | 7,8-dihydroxyflavone, a small molecular TrkB agonist, is useful for treating various BDNF-implicated human disorders | Translational Neurodegeneration | 2016 | 129 |
| 21 | miRNA expression profiles in cerebrospinal fluid and blood of patients with Alzheimer’s disease and other types of dementia – an exploratory study | Translational Neurodegeneration | 2016 | 126 |
| 22 | Brain-derived neurotrophic factor in Alzheimer’s disease and its pharmaceutical potential | Translational Neurodegeneration | 2022 | 117 |
| 23 | Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration | Translational Neurodegeneration | 2022 | 117 |
| 24 | The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease | Translational Neurodegeneration | 2017 | 115 |
| 25 | Recent advances in transthyretin amyloidosis therapy | Translational Neurodegeneration | 2014 | 113 |
| 26 | Exploratory study on microRNA profiles from plasma-derived extracellular vesicles in Alzheimer’s disease and dementia with Lewy bodies | Translational Neurodegeneration | 2019 | 112 |
| 27 | Efficient RT-QuIC seeding activity for α-synuclein in olfactory mucosa samples of patients with Parkinson’s disease and multiple system atrophy | Translational Neurodegeneration | 2019 | 106 |
| 28 | Pathological correlations between traumatic brain injury and chronic neurodegenerative diseases | Translational Neurodegeneration | 2017 | 104 |
| 29 | Role of early life exposure and environment on neurodegeneration: implications on brain disorders | Translational Neurodegeneration | 2014 | 102 |
| 30 | The role of exosomes in the pathogenesis of Alzheimer’ disease | Translational Neurodegeneration | 2017 | 101 |
| 31 | Endoplasmic reticulum-mitochondria tethering in neurodegenerative diseases | Translational Neurodegeneration | 2017 | 97 |
| 32 | Exercise-induced increase in brain-derived neurotrophic factor in human Parkinson's disease: a systematic review and meta-analysis | Translational Neurodegeneration | 2018 | 97 |
| 33 | Advances in the pathogenesis of Alzheimer’s disease: a re-evaluation of amyloid cascade hypothesis | Translational Neurodegeneration | 2012 | 94 |
| 34 | Voxel-based meta-analysis of grey matter changes in Alzheimer’s disease | Translational Neurodegeneration | 2015 | 91 |
| 35 | The study of brain functional connectivity in Parkinson’s disease | Translational Neurodegeneration | 2016 | 90 |
| 36 | Parkinson’s disease in China: a forty-year growing track of bedside work | Translational Neurodegeneration | 2019 | 89 |
| 37 | The emerging roles of vacuolar-type ATPase-dependent Lysosomal acidification in neurodegenerative diseases | Translational Neurodegeneration | 2020 | 89 |
| 38 | Posttranslational modifications of α-tubulin in alzheimer disease | Translational Neurodegeneration | 2015 | 88 |
| 39 | Drug therapy in patients with Parkinson’s disease | Translational Neurodegeneration | 2012 | 84 |
| 40 | Peripheral clearance of brain-derived Aβ in Alzheimer's disease: pathophysiology and therapeutic perspectives | Translational Neurodegeneration | 2020 | 83 |
| 41 | Traditional Chinese medicine: a promising candidate for the treatment of Alzheimer’s disease | Translational Neurodegeneration | 2013 | 82 |
| 42 | Reduced striatal volumes in Parkinson’s disease: a magnetic resonance imaging study | Translational Neurodegeneration | 2012 | 81 |
| 43 | Role of BACE1 in Alzheimer’s synaptic function | Translational Neurodegeneration | 2017 | 80 |
| 44 | Freezing of gait in Parkinson’s disease: pathophysiology, risk factors and treatments | Translational Neurodegeneration | 2020 | 80 |
| 45 | Dysregulation of autophagy and mitochondrial function in Parkinson’s disease | Translational Neurodegeneration | 2016 | 79 |
| 46 | Current progress of mitochondrial transplantation that promotes neuronal regeneration | Translational Neurodegeneration | 2019 | 78 |
| 47 | The associations between Parkinson’s disease and cancer: the plot thickens | Translational Neurodegeneration | 2015 | 77 |
| 48 | Stepping closer to treating Alzheimer’s disease patients with BACE1 inhibitor drugs | Translational Neurodegeneration | 2016 | 77 |
| 49 | Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer’s disease –conformist, nonconformist, and realistic prospects for AD pathogenesis | Translational Neurodegeneration | 2018 | 77 |
| 50 | Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome | Translational Neurodegeneration | 2018 | 76 |
